Literature DB >> 21103183

Commentary on N. Ghaemi's "Hippocratic Psychopharmacology of Bipolar Disorder" Treating Bipolar Disorder: For the Patient or Against the Illness?

Alan C Swann1.   

Abstract

OBJECTIVE: This is a commentary on Hippocratic Psychopharmacology in Bipolar Disorder, an article by S. Nasir Ghaemi in this issue of Psychiatry 2006.
DESIGN: Based on Dr. Ghaemi's article and relevant literature, I discuss implications of Hippocratic treatment, i.e., the principle of treating an underlying illness using methods that enhance the patient's adaptive responses, rather than using symptomatic treatments. RESULTS AND DISCUSSION: Key points include 1) the course of illness, as heterogeneous as it is, seems to have episodic-stable and inherently unstable forms; 2) course of illness interacts with episode characteristics, with mixed or polyphasic episodes associated with an unstable and complicated course of illness; 3) consequences in terms of treatment response, with lithium being more effective in treating the episodic-stable than the unstable form of the illness; and 4) the fact that, in determining treatment response, course of illness trumps episode characteristics. The goal of Hippocratic/Oslerian medicine, curative treatment aimed at underlying mechanisms of disease, is the aim of treatment, but is still elusive.

Entities:  

Keywords:  Bipolar disorder; course of illness; prophylaxis; psychopharmacology; recurrence

Year:  2006        PMID: 21103183      PMCID: PMC2990644     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  19 in total

1.  Impact of family burden and patient symptom status on clinical outcome in bipolar affective disorder.

Authors:  D A Perlick; R R Rosenheck; J F Clarkin; P Raue; J Sirey
Journal:  J Nerv Ment Dis       Date:  2001-01       Impact factor: 2.254

2.  Sources of lithium resistance in mixed mania.

Authors:  J M Himmelhoch; M E Garfinkel
Journal:  Psychopharmacol Bull       Date:  1986

3.  Lithium prophylaxis in recurrent affective illness.

Authors:  R F Prien; C J Klett; E M Caffey
Journal:  Am J Psychiatry       Date:  1974-02       Impact factor: 18.112

4.  Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness.

Authors:  D L Dunner; F Stallone; R R Fieve
Journal:  Arch Gen Psychiatry       Date:  1976-01

5.  A history of substance abuse complicates remission from acute mania in bipolar disorder.

Authors:  J F Goldberg; J L Garno; A C Leon; J H Kocsis; L Portera
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

6.  Long-term prognosis of bipolar I disorder.

Authors:  C L Turvey; W H Coryell; D A Solomon; A C Leon; J Endicott; M B Keller; H Akiskal
Journal:  Acta Psychiatr Scand       Date:  1999-02       Impact factor: 6.392

7.  Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants.

Authors:  A C Swann; P L Janicak; J R Calabrese; C L Bowden; S C Dilsaver; D D Morris; F Petty; J M Davis
Journal:  J Affect Disord       Date:  2001-12       Impact factor: 4.839

Review 8.  Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.

Authors:  T Suppes; R J Baldessarini; G L Faedda; M Tohen
Journal:  Arch Gen Psychiatry       Date:  1991-12

9.  Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients.

Authors:  R R Fieve; T Kumbaraci; D L Dunner
Journal:  Am J Psychiatry       Date:  1976-08       Impact factor: 18.112

10.  A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

Authors:  Guy M Goodwin; Charles L Bowden; Joseph R Calabrese; Heinz Grunze; Siegfried Kasper; Robin White; Paul Greene; Robert Leadbetter
Journal:  J Clin Psychiatry       Date:  2004-03       Impact factor: 4.384

View more
  1 in total

Review 1.  Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.

Authors:  Alexander C Tsai; Nicholas Z Rosenlicht; Jon N Jureidini; Peter I Parry; Glen I Spielmans; David Healy
Journal:  PLoS Med       Date:  2011-05-03       Impact factor: 11.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.